Lewis W. Coleman, Director at Immune Design Corp. (IMDZ), bought 50,000 shares at $4.50 ($225K) on 2017-11-02, disclosed to the SEC on 2017-11-06.
Open-market purchase of $225k IMDZ by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| IMDZ | BUY | 2017-07-10 | $74K | — | Filing → |
| IMDZ | SELL | 2016-12-27 | $62K | — | Filing → |
| IMDZ | BUY | 2016-09-20 | $250K | — | Filing → |